Dr. Christopher Cogle
I've won the following awards
Scholar in Clinical Research, Leukemia and Lymphoma Society
Young Investigator Award, American Society of Clinical Oncology
Bench to Bedside Award, UF Health Cancer Center
Top 10 Young Stem Cell Scientist, UK British Council
Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.
Cytokine Growth Factor Rev., 21(2-3):169-75 (2010)
Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.
Clin Adv Hematol Oncol., Jan;8(1):40-6 (2010)
The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo.
J. Biol. Chem., Feb;286(6):4280-91 (2011)
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries.
Blood., Jun;117(26):7121-5 (2011)
Angiogenesis in acute myeloid leukemia and opportunities for novel therapies.
J Oncol., 2012:128608 (2012)
The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow.
Neoplasia., Nov;13(11):1058-68 (2011)
Oncolytic virotherapy for hematological malignancies.
Adv Virol., 2012:186512 (2012)
An overview of stem cell research and regulatory issues.
Mayo Clin. Proc., Aug;78(8):993-1003 (2003)
Adult human hematopoietic cells provide functional hemangioblast activity.
Blood., Jan;103(1):133-5 (2004)
Bone marrow transdifferentiation in brain after transplantation: a retrospective study.
Lancet., May;363(9419):1432-7 (2004)
Developmental differences in megakaryocyte maturation are determined by the microenvironment.
Stem Cells., Oct;23(9):1400-8 (2005)
Typhlitis with concurrent appendicitis in a patient with chronic lymphocytic leukemia.
Clin Adv Hematol Oncol., May;1(5):284-6; discussion 286 (2003)
Stem cell research.
Paediatr Respir Rev., Jun;7(2):135-40 (2006)
Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry.
Stem Cells., Aug;25(8):1881-7 (2007)
The hunt for cancer-initiating cells: a history stemming from leukemia.
Leukemia., Aug;21(8):1619-27 (2007)
Marrow cell therapies for cardiovascular diseases.
Exp. Hematol., Jun;36(6):687-94 (2008)
Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma.
Am. J. Hematol., Jul;73(3):169-75 (2003)
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.
Leuk. Res., May;36(5):619-24 (2012)
Aldehyde dehydrogenase activity as a functional marker for lung cancer.
Chem. Biol. Interact., Mar;178(1-3):48-55 (2009)
Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromes.
Leuk. Res., Nov;35(11):1453-6 (2011)